I write in response to the article by McLernon et al. 1 that appeared in a recent issue of the Journal of Medical Screening. I found the article to be an interesting analysis of what seems to be a very-well-conducted observational study.
There are several issues, related primarily to presentation, that I wish to raise. First, when describing the method, attributed to Begg, used to account for selection bias, the authors state, 'This probability of biopsy was then used to weight the final logistic regression model'. While this is arguably clear enough, it is just as concise and much more transparent to say that the final logistic regression model was weighted using the reciprocal of the predicted probabilities of biopsy.
Second, in using Begg's method, the authors appear to assume that the decision to take up biopsy and diagnosing prostate cancer (either observed or unobserved) are statistically independent within levels of prostate-specific antigen (PSA) and age. The level of success achieved in applying Begg's method to remove selection bias depends upon the degree to which dependence between the two has been reduced within levels of the explanatory variables.
In addition to PSA and age, another strong indicator of both the decision to take up biopsy and a prostate cancer diagnosis is likely to be a digital rectal exam (DRE). The connection between DRE and decision to biopsy has been reported by Pinsky et al., 2 while the connection between DRE and the diagnosis of prostate cancer was reported by Andriole et al. 3 In order to point out the possible magnitude of selection bias that could remain when the independence assumption does not hold, I simulated a data-set containing age, PSA, DRE, decision to take up biopsy and prostate cancer diagnosis. The latter was generated for all individuals so that Begg's method applied to an analysis of individuals who underwent biopsy could be compared with an idealized situation in which all individuals had undergone biopsy.
The simulated data-set was constructed to share basic properties of the data-set analysed in the report.
The effects of age and PSA on the probability of receiving a cancer diagnosis were analysed via a logistic regression fitted to the data on individuals who underwent biopsy. This logistic regression model was weighted using the reciprocal of the predicted probabilities of biopsy, which were derived from a logistic regression of age and PSA on the decision to take up biopsy in the full data-set. The effect of PSA on the probability of a prostate cancer diagnosis was measured to be a logged odds of 0.471 (95% confidence interval [CI] 0.422, 0.520). However, an analysis of the full data-set, representing the idealized situation in which everyone had undergone biopsy, resulted in a corresponding logged odds of 0.398 (95% CI 0.382, 0.414). This represents an upward bias on the logged-odds scale of roughly 18%, which many investigators and clinicians would not consider negligible.
When the independence is reasonable, Begg's method works. Indeed, when the above models included DRE, the logged-odds resulting from an analysis using Begg's method becomes 0.353 (95% CI 0.304, 0.402) and the corresponding full sample estimate becomes 0.372 (95% CI 0.356, 0.389). These are nearly identical from both clinical and statistical standpoints.
In conclusion, it is understandable when the limitations of available data preclude inclusion of all the important prognostic factors. The fact that DRE was not available in the authors' dataset does not make their study or their analysis any less interesting, at least from the standpoint of methodology. However, it is always important to state explicitly what assumptions are required in applying any statistical method.
